Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurotransmitters and alcoholism: methodological issues.

M Linnoila1

  • 1Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD 20892.

Advances in Alcohol & Substance Abuse
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cladistic association analysis of Y chromosome effects on alcohol dependence and related personality traits.

Proceedings of the National Academy of Sciences of the United States of America·1999
Same author

Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers.

Journal of neurochemistry·1999
Same author

No coding variant of the tryptophan hydroxylase gene detected in seasonal affective disorder, obsessive-compulsive disorder, anorexia nervosa, and alcoholism.

Biological psychiatry·1999
Same author

Buspirone treatment of alcoholism: age of onset, and cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid concentrations, but not medication treatment, predict return to drinking.

Alcoholism, clinical and experimental research·1999
Same author

The combined effects of chronic ethanol/desipramine treatment on beta-adrenoceptor density and coupling efficiency in rat brain.

European journal of pharmacology·1999
Same author

Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations.

Archives of general psychiatry·1998
Same journal

Drug dependence: defining the issues.

Advances in alcohol & substance abuse·1990
Same journal

Reactions of methadone patients to HIV antibody testing.

Advances in alcohol & substance abuse·1990
Same journal

Smoking behavior in nine year old children: a replication and extension study.

Advances in alcohol & substance abuse·1990
Same journal

Relationship between morbidity and mortality due to alcoholic cardiomyopathy and alcohol consumption in Australia.

Advances in alcohol & substance abuse·1990
Same journal

Alcohol consumption and pain phobia: toward a unifying theory of alcoholism.

Advances in alcohol & substance abuse·1990
Same journal

The diagnosis of alcohol and cannabis dependence in cocaine dependence.

Advances in alcohol & substance abuse·1990
See all related articles

This review explores neurochemical differences in alcoholics, focusing on serotonin and norepinephrine. Controlling for clinical variables in cerebrospinal fluid is crucial for accurate comparisons in alcoholism research.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Biochemistry

Background:

  • Alcoholism is associated with complex neurochemical alterations.
  • Understanding these differences is key to developing effective treatments.
  • Previous research has yielded varied results, necessitating a focused review.

Purpose of the Study:

  • To review recent findings on neurochemical differences between alcoholics and control groups.
  • To emphasize the impact of clinical variables on neurotransmitter metabolite concentrations.
  • To guide future research by highlighting critical factors for comparison.

Main Methods:

  • Literature review of recent studies.
  • Analysis of cerebrospinal fluid (CSF) neurotransmitter metabolite concentrations.

Related Experiment Videos

  • Focus on serotonin and norepinephrine in relation to alcoholism.

    • Main Results:

    • Clinical variables significantly influence neurotransmitter metabolite levels in CSF.
    • Serotonin and norepinephrine metabolite concentrations show notable differences in alcoholics.
    • Standardization of clinical variable control is essential for reliable findings.

    Conclusions:

    • Neurochemical differences, particularly in serotonin and norepinephrine, are evident in alcoholism.
    • Controlling for clinical factors in CSF analysis is paramount for valid research.
    • Further investigation into these specific neurotransmitters may reveal therapeutic targets.